Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
Financials
Financial year 2025
MRSA from Genk, company number BE0830266154, closed financial year 2025 with a result of € -95 after tax. For that financial year MRSA recorded a gross margin of € 2,475 and equity of € 14,577. Compared with financial year 2024, the result moved from € 5,927 to € -95. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 5, 2026.
€ 14,577
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -95
▼ still € 5,927 profit in 2024
Profit after tax over the fiscal year.
€ 12,276
▼ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 8,377.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,128
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 526
▼ 92% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 6,282 | € 9,205 | € 12,351 | € 2,475 | ▼ 80% |
| Profit after taxes | € 3,601 | € 6,063 | € 5,927 | € -95 | ▼ € 6,022 |
| Equity | € 1,375 | € 7,439 | € 13,365 | € 14,577 | ▲ 9% |
| Total debts | € 27,464 | € 24,870 | € 21,043 | € 13,117 | ▼ 38% |
| Cash | € 11,038 | € 4,006 | € 13,409 | € 12,276 | ▼ 8% |
| Retained profit | € -4,825 | € 1,239 | € 7,165 | € 8,377 | ▲ 17% |
| Balance sheet total | € 28,839 | € 32,309 | € 34,409 | € 27,694 | ▼ 20% |
By gross margin, MRSA ranks 13th of 15 companies with main activity “Overige werkzaamheden in verband met de afwerking van gebouwen” in Genk that publish figures (fiscal year 2025).
Key figures of MRSA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about MRSA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MRSA?
What happened at MRSA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Genk. KBO
- Mauro Piroddi became a director. NBB
In short
From € 3,601 profit in 2022 to € 95 loss in 2025.
Paid € 8,102 in corporate taxes since 2022.
Best year ever: 2023, with € 6,063 profit.
Management
Behind MRSA is Mauro Piroddi.
Directors
According to the 2025 annual accounts
Mauro Piroddi
Manager
since 2010
Establishments
Establishment units
Physical locations of this company
Veertien Septemberlaan 48
3600 Genk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Genk
Same main activity (Overige werkzaamheden in verband met de afwerking van gebouwen), 18 active companies in Genk, largest first.
€ 565,840 gross margin · 2025
€ 133,652 gross margin · 2024
€ 93,745 gross margin · 2025
€ 85,447 gross margin · 2025
€ 54,219 gross margin · 2025
€ 45,471 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- PIRODDI Mauro(oprichter) 95%
- JONCKHEER Roberto(oprichter) 5%
Details
- Company number
- 0830.266.154
- VAT number
- BE 0830.266.154
- Registered office
- Veertien Septemberlaan 48, 3600 Genk
- Names & denominations
- MRSA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 October 2010
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Overige werkzaamheden in verband met de afwerking van gebouwen